Indaptus Therapeutics, Inc. (INDP)
NASDAQ: INDP · Real-Time Price · USD
0.836
-0.008 (-0.97%)
Dec 27, 2024, 4:00 PM EST - Market closed
Indaptus Therapeutics Market Cap
Indaptus Therapeutics has a market cap or net worth of $8.52 million as of December 27, 2024. Its market cap has decreased by -47.71% in one year.
Market Cap
8.52M
Enterprise Value
1.25M
1-Year Change
-47.71%
Ranking
Category
Stock Price
$0.84
Market Cap Chart
Since August 4, 2015, Indaptus Therapeutics's market cap has decreased from $60.70M to $8.52M, a decrease of -85.96%. That is a compound annual growth rate of -18.84%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Dec 27, 2024 | 8.50M | -42.57% |
Dec 29, 2023 | 14.80M | 23.33% |
Dec 30, 2022 | 12.00M | -74.30% |
Dec 31, 2021 | 46.70M | 243.38% |
Dec 31, 2020 | 13.60M | -22.29% |
Dec 31, 2019 | 17.50M | -91.10% |
Dec 31, 2018 | 196.60M | 233.22% |
Dec 29, 2017 | 59.00M | -9.65% |
Dec 30, 2016 | 65.30M | 20.48% |
Dec 31, 2015 | 54.20M | -10.71% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
BiomX | 9.88M |
Kiora Pharmaceuticals | 9.87M |
Purple Biotech | 9.64M |
Eyenovia | 9.54M |
Applied DNA Sciences | 9.37M |
Zhongchao | 9.26M |
Aytu BioPharma | 9.22M |
BioCardia | 9.17M |